J.L. Moake

733 total citations
22 papers, 565 citations indexed

About

J.L. Moake is a scholar working on Hematology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J.L. Moake has authored 22 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 8 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J.L. Moake's work include Platelet Disorders and Treatments (12 papers), Complement system in diseases (8 papers) and Blood properties and coagulation (5 papers). J.L. Moake is often cited by papers focused on Platelet Disorders and Treatments (12 papers), Complement system in diseases (8 papers) and Blood properties and coagulation (5 papers). J.L. Moake collaborates with scholars based in United States, Austria and Netherlands. J.L. Moake's co-authors include Timothy M. Wick, Mark M. Udden, Leticia Nolasco, Nancy A. Turner, Evan Vosburgh, Mark Weinstein, K. J. Moise, Rita A. Blanchard, J. D. Hellums and Clarence P. Alfrey and has published in prestigious journals such as Blood, Annals of Internal Medicine and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

J.L. Moake

22 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.L. Moake United States 11 338 229 127 114 83 22 565
Junji Tomiyama Japan 13 235 0.7× 153 0.7× 100 0.8× 83 0.7× 65 0.8× 47 565
Adriana Hornstein Canada 10 437 1.3× 111 0.5× 78 0.6× 64 0.6× 28 0.3× 13 568
J. M. Heal United States 9 314 0.9× 85 0.4× 60 0.5× 44 0.4× 47 0.6× 11 518
Kip R. Hartman United States 10 527 1.6× 71 0.3× 420 3.3× 67 0.6× 13 0.2× 15 748
W E Hathaway United States 10 266 0.8× 109 0.5× 72 0.6× 78 0.7× 9 0.1× 14 497
Jane Keidan United Kingdom 7 437 1.3× 119 0.5× 102 0.8× 25 0.2× 11 0.1× 9 589
Robert C. Blaylock United States 8 160 0.5× 80 0.3× 34 0.3× 46 0.4× 39 0.5× 18 337
S Yano Japan 10 42 0.1× 156 0.7× 52 0.4× 134 1.2× 137 1.7× 30 546
Bora Gülhan Türkiye 15 91 0.3× 176 0.8× 39 0.3× 129 1.1× 206 2.5× 63 629
Kjell A. Grøttum Norway 12 257 0.8× 36 0.2× 41 0.3× 140 1.2× 20 0.2× 21 541

Countries citing papers authored by J.L. Moake

Since Specialization
Citations

This map shows the geographic impact of J.L. Moake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.L. Moake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.L. Moake more than expected).

Fields of papers citing papers by J.L. Moake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.L. Moake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.L. Moake. The network helps show where J.L. Moake may publish in the future.

Co-authorship network of co-authors of J.L. Moake

This figure shows the co-authorship network connecting the top 25 collaborators of J.L. Moake. A scholar is included among the top collaborators of J.L. Moake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.L. Moake. J.L. Moake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turner, Nancy A., Sarah E. Sartain, & J.L. Moake. (2015). Ultralarge Von Willebrand Factor–Induced Platelet Clumping and Activation of the Alternative Complement Pathway in Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic Syndromes. Hematology/Oncology Clinics of North America. 29(3). 509–524. 19 indexed citations
2.
Zhou, Z. Hong, W. Stratford May, Chunlei Wang, et al.. (2010). Disulfide bond reduction of von Willebrand factor by ADAMTS‐13. Journal of Thrombosis and Haemostasis. 8(12). 2778–2788. 40 indexed citations
3.
Li, Yanxia, Z. Hong Zhou, Leticia Nolasco, et al.. (2008). Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions. Journal of Thrombosis and Haemostasis. 6(7). 1135–1143. 56 indexed citations
4.
Moake, J.L., et al.. (2000). Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Current Opinion in Pediatrics. 12(1). 23–28. 30 indexed citations
5.
Linneweber, Joerg, T. Takano, Takuya Maeda, et al.. (2000). DIRECT DETECTION OF RED BLOOD CELL FRAGMENTS. ASAIO Journal. 46(2). 182–182. 1 indexed citations
6.
Chow, Thomas, Nancy A. Turner, Murali Chintagumpala, et al.. (1998). Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. American Journal of Hematology. 57(4). 293–302. 80 indexed citations
7.
Ross, Jacqueline, L.V. McIntire, J.L. Moake, et al.. (1998). Fibrillin containing elastic microfibrils support platelet adhesion under dynamic shear conditions.. PubMed. 79(1). 155–61. 15 indexed citations
8.
Wick, Timothy M., et al.. (1993). Unusually large von willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells. American Journal of Hematology. 42(3). 284–292. 77 indexed citations
9.
Weinstein, Mark, Rita A. Blanchard, J.L. Moake, Evan Vosburgh, & K. J. Moise. (1989). Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura. British Journal of Haematology. 72(1). 68–72. 74 indexed citations
10.
Jarolı́m, Petr, J Palek, Thérèsa L. Coetzer, et al.. (1989). Severe hemolysis and red cell fragmentation caused by the combination of a spectrin mutation with a thrombotic microangiopathy. American Journal of Hematology. 32(1). 50–56. 9 indexed citations
11.
Olson, John D., Howard H. Kaufman, J.L. Moake, et al.. (1989). The Incidence and Significance of Hemostatic Abnormalities in Patients with Head Injuries. Survey of Anesthesiology. 33(6). 369–369. 6 indexed citations
12.
Moake, J.L., et al.. (1982). Effects of colchicine and vinblastine on platelet contractility and release. Thrombosis Research. 26(5). 329–339. 7 indexed citations
13.
Hellums, J. D., et al.. (1980). Effects of antiplatelet agents on platelets exposed to shear stress.. PubMed. 26. 179–84. 9 indexed citations
14.
Kirkpatrick, John P., L.V. McIntire, J.L. Moake, & Darrell L. Peterson. (1979). Dynamic Rheological Studies of Coagulation and Fibrinolysis. Journal of Rheology. 23(6). 769–787. 10 indexed citations
15.
McIntire, Larry V., et al.. (1978). Rheological studies of the contractile force within platelet-fibrin clots: Effects of prostaglandin E1, dibutyryl-cAMP and dibutyryl-cGMP. Thrombosis Research. 13(6). 957–969. 8 indexed citations
17.
Moake, J.L., et al.. (1977). Intravascular Hemolysis, Thrombocytopenia, Leukopenia, and Circulating Immune Complexes after Jejunal-Ileal Bypass Surgery. Annals of Internal Medicine. 86(5). 576–578. 25 indexed citations
18.
Moake, J.L., et al.. (1976). Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets.. PubMed. 87(1). 49–57. 10 indexed citations
19.
Moake, J.L., et al.. (1970). Mg2+-dependent, (Na+ + K+)-stimulated ATPase of human platelets. Biochimica et Biophysica Acta (BBA) - Biomembranes. 211(2). 337–344. 32 indexed citations
20.
Moake, J.L., Khalil Ahmed, & N R Bachur. (1970). Reversal by adenosine of ADP inhibition of platelet (Na+ + K+)-ATPase. Biochimica et Biophysica Acta (BBA) - Biomembranes. 219(2). 484–485. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026